rdf:type |
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0016441,
umls-concept:C0030705,
umls-concept:C0079731,
umls-concept:C0087111,
umls-concept:C0205099,
umls-concept:C0205210,
umls-concept:C0205225,
umls-concept:C0221912,
umls-concept:C0332293,
umls-concept:C0439659,
umls-concept:C1522449,
umls-concept:C1571705,
umls-concept:C2717829
|
pubmed:issue |
2
|
pubmed:dateCreated |
1996-7-9
|
pubmed:abstractText |
Primary cutaneous follicle center cell lymphomas (PCFCCL) are a distinct group of cutaneous B-cell lymphomas with a favorable prognosis after radiotherapy (RT) or polychemotherapy (PCT). In the literature, conflicting data exist regarding the efficacy and the relapse rate of both treatment modalities. In the present study, treatment results and follow-up data of a large group of PCFCCL are evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
549-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8636770-Adult,
pubmed-meshheading:8636770-Aged,
pubmed-meshheading:8636770-Aged, 80 and over,
pubmed-meshheading:8636770-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8636770-Cyclophosphamide,
pubmed-meshheading:8636770-Doxorubicin,
pubmed-meshheading:8636770-Female,
pubmed-meshheading:8636770-Follow-Up Studies,
pubmed-meshheading:8636770-Humans,
pubmed-meshheading:8636770-Hydrocortisone,
pubmed-meshheading:8636770-Lymphoma, B-Cell,
pubmed-meshheading:8636770-Male,
pubmed-meshheading:8636770-Methotrexate,
pubmed-meshheading:8636770-Methylprednisolone,
pubmed-meshheading:8636770-Middle Aged,
pubmed-meshheading:8636770-Prednisone,
pubmed-meshheading:8636770-Skin Neoplasms,
pubmed-meshheading:8636770-Vincristine
|
pubmed:year |
1996
|
pubmed:articleTitle |
Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.
|
pubmed:affiliation |
Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|